Group One Trading, L.P. Natera, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $281,737 - $469,987	7,503 New	7,503 $469,000
Q2 2023 Aug 09, 2023	BUY	$47.08 - $55.16 $191,945 - $224,887	4,077 New	4,077 $198,000
Q3 2022 Nov 09, 2022	BUY	$36.93 - $56.68 $549,555 - $843,455	14,881 New	14,881 $652,000
Q2 2022 Aug 11, 2022	SELL	$28.13 - $44.54 $1.03 Million - $1.63 Million	-36,500 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$30.32 - $91.33 $1.11 Million - $3.33 Million	36,500 New	36,500 $1.49 Million
Q2 2021 Aug 10, 2021	SELL	$86.05 - $119.72 $156,094 - $217,172	-1,814 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$91.47 - $124.36 $53,509 - $72,750	585 Added 47.6%	1,814 $184,000
Q4 2020 Feb 10, 2021	BUY	$66.66 - $111.74 $81,925 - $137,328	1,229 New	1,229 $122,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.